GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01548 GENSCRIPT BIO

Market Closed 04-17 16:08:14

13.760

+0.010

+0.07%

High13.900	Low13.630	Vol8.44M
Open13.800	D1 Closing13.750	Amplitude1.96%
Mkt Cap30.11B	Tradable Cap30.11B	Total Shares2.19B
T/O116.15M	T/O Rate0.39%	Tradable Shares2.19B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"GENSCRIPT BIO","latestPrice":13.76,"timestamp":1776413294005,"preClose":13.75,"halted":0,"volume":8441644,"delay":0,"changeRate":0.0007272727272727117,"floatShares":2188000000,"shares":2188000000,"eps":-1.9268457112396717,"marketStatus":"Market Closed","change":0.01,"latestTime":"04-17 16:08:14","open":13.8,"high":13.9,"low":13.63,"amount":116149801,"amplitude":0.019636,"askPrice":13.79,"askSize":46000,"bidPrice":13.76,"bidSize":18000,"shortable":3,"etf":0,"ttmEps":-1.9268457112396717,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":7,"adr":0,"listingDate":1451404800000,"exchange":"SEHK","adjPreClose":13.75,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.9027217384710137,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548","defaultTab":"news","newsList":[{"id":"2627340353","title":"BUZZ-Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2627340353","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627340353?lang=en_us&edition=fundamental","pubTime":"2026-04-15 13:59","pubTimestamp":1776232791,"startTime":"0","endTime":"0","summary":"BUZZ-Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales** Shares of Genscript Biotech Corporation 1548.HK climb 4.5% to HK$13.27, on track for the biggest one-day pct gain since April 1** Stock hit the highest level since April 9 in the second session of rise** Genscript said its associate Legend Biotech Corp LEGN.O announced that blood cancer drug CARVYKTI generated about $597 mln in net trade sales during the quarter ended in March 2026** YTD, Genscript Hong Kong stock up 6.2%, Hang Seng Biotech Index .HSBIO up 11.9%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL1N40Y04Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1141","BK1583","LEGN","HK0000320223.HKD","HK0000306685.HKD","HK0000320264.USD","BK4588","BK4505","HK0000306701.USD","01548","BK1576","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105253038","title":"GENSCRIPT BIO Reports $597 Million Net Trade Sales for CARVYKTI® in Quarter Ending March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1105253038","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105253038?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:09","pubTimestamp":1776168571,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO announced that, under the collaboration and license agreement signed on December 21, 2017, between Legend Biotech Corporation (an associate of the company whose shares are listed on the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","BK1141","HK0000320223.HKD","01548","BK1576","HK0000306701.USD","HK0000320264.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445959","title":"GenScript announces availability of 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445959?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:04","pubTimestamp":1776168269,"startTime":"0","endTime":"0","summary":"GenScript released its 2025 Environmental, Social, and Governance  Report, outlining climate, governance, supply-chain, workforce, and community priorities.Science Based Targets initiative validated GenScript decarbonization targets aligned with a 1.5°C pathway, with net-zero ambition by 2050.Workforce totaled 6,165 employees, with 58% female representation and nearly 50% women in leadership roles.Supply-chain program reported 100% of targeted suppliers aligned with Supplier Code of Conduct.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL3bzKsh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930730.SGD","BK1583","LU0511384066.AUD","BK1141","LU0672654240.SGD","BK4112","HK0000320223.HKD","LU0289960550.SGD","IE00BKPKM429.USD","LU2265009873.SGD","BK1576","BK4585","LU0390134368.USD","LU0320765059.SGD","LU0175139822.USD","LU1691799644.USD","LU0289961442.SGD","LU0109391861.USD","LU0289739343.SGD","LU0708995401.HKD","HK0000320264.USD","HK0000306685.HKD","LU2210149790.SGD","MSCI","LU2095319765.USD","HK0000306701.USD","01548","LU1804176565.USD","BK4588","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188331019","title":"Genscript: Legend Biotech Posts US$597.00 Million CARVYKTI® Net Sales for Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1188331019","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188331019?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:03","pubTimestamp":1776168205,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (GENSCRIPT BIO, 01548) announced that its associate Legend Biotech Corporation has reported preliminary net trade sales of approximately US$597.00 million for CARVYKTI®...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627454565","title":"A Look At GenScript Biotech (SEHK:1548) Valuation After New DNA Data Storage Collaboration With Mimulus","url":"https://stock-news.laohu8.com/highlight/detail?id=2627454565","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627454565?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:19","pubTimestamp":1776093552,"startTime":"0","endTime":"0","summary":"Genscript Biotech (SEHK:1548) is back in focus after announcing a multi year collaboration with Mimulus Corp to industrialize DNA based data storage, targeting scalable infrastructure and substantial cost efficiencies by 2030.\nSee our latest analysis for Genscript Biotech.\nThe collaboration headlines come as Genscript Biotech's share price, now at HK$12.62, shows mixed momentum, with a 13.8% 1 month share price return but a 12.42% decline over 3 months. The 1 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/a-look-at-genscript-biotech-sehk1548-valuation-after-new-dna","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/a-look-at-genscript-biotech-sehk1548-valuation-after-new-dna","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","HK0000306685.HKD","01548","BK4585","BK4581","BK4139","BK1576","HK0000306701.USD","BK1141","BK1583","HK0000320223.HKD","HK0000320264.USD","DNA","BK4109","BK4121","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163044898","title":"GenScript Reports 2025 ESG Progress: 10% Emissions Drop, 58% Female Workforce and SBTi-Aligned Net-Zero Roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=1163044898","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163044898?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:44","pubTimestamp":1776077074,"startTime":"0","endTime":"0","summary":"GenScript Biotech released its 10th annual Environmental, Social and Governance (ESG) report, detailing 2025 performance and disclosing Science Based Targets initiative (SBTi)-validated goals that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115837701","title":"GENSCRIPT BIO Sets 5 June 2026 AGM; Shareholders to Vote on FY-2025 Statements, Director Re-elections and 20% Issuance Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1115837701","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115837701?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:44","pubTimestamp":1776077059,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (abbreviated as GENSCRIPT BIO) has circulated the proxy form for its 2026 Annual General Meeting (AGM), confirming the session will take place at 9:30 a.m. on Friday, 5...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165590040","title":"GenScript Bio to Seek 20% Issuance Headroom, 10% Buy-Back Capacity and Charter Revamp at 5 June 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1165590040","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165590040?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:43","pubTimestamp":1776076997,"startTime":"0","endTime":"0","summary":"GenScript Biotech Corporation has dispatched its 2026 AGM circular outlining several key resolutions to be tabled on 5 June 2026 at the company’s Jiangning District headquarters. General Mandates   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431341","title":"GenScript publishes 2025 environmental, social and governance report","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431341","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431341?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:07","pubTimestamp":1776074872,"startTime":"0","endTime":"0","summary":"GenScript issued its 2025 environmental, social, and governance report, outlining progress against decarbonization targets validated by Science Based Targets initiative, with net-zero ambition set for 2050.ESG oversight centered on board-level Risk Management and ESG Committee, supported by an ESG working team spanning operating functions.Workforce totaled 6,165, with female representation above 58%.Employee training coverage reached 100%, with total training hours up 18% from 2024.ESG ratings cited included MSCI ESG “AA” plus Sustainalytics “Low Risk” for 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Ser","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL6K4FYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000306701.USD","BK1576","HK0000320223.HKD","HK0000306685.HKD","01548","BK1583","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627143137","title":"GenScript Biotech announces annual general meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2627143137","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627143137?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:07","pubTimestamp":1776074857,"startTime":"0","endTime":"0","summary":"GenScript Biotech scheduled 2026 annual general meeting in Jiangning District for June 5, 2026.Shareholders will vote on adoption of audited consolidated financial statements for fiscal year 2025.Ballots include re-election of directors, including Jiange Meng, Fangliang Zhang, Li Zhu, Chenyang Shi.Meeting will consider reappointment of Ernst & Young as auditor.Resolutions seek mandates to issue up to 20% of outstanding shares, buy back up to 10%, extend issuance mandate by shares repurchased.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 13, 2026, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL9B8NTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD","BK1583","HK0000320264.USD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125369956","title":"金斯瑞生物科技2025年营收大增61.4%至9.60亿美元，受Legend投资减值影响净亏损5.32亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125369956","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125369956?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:26","pubTimestamp":1776072405,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技（股份代号：01548，简称“GENSCRIPT BIO”）于2025年财年实现收入约9.595亿美元，同比上升61.4%，主要得益于授权收入的显著增长及其他业务板块的稳健表现。同时，公司整体毛利从上一年度的2.721亿美元增长至5.532亿美元，毛利率由45.8%提升至57.7%。...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627357844","title":"GenScript Biotech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2627357844","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627357844?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:08","pubTimestamp":1776071316,"startTime":"0","endTime":"0","summary":"GenScript Biotech released its 2025 annual report, highlighting strong top-line momentum across core platforms, led by a step-change in licensing activity at ProBio.ProBio shifted to profitability on an adjusted basis, supported by sublicense income tied to LaNova’s PD-1/VEGF bispecific program.GenScript Life Science Group expanded gene-to-protein workflows, supported by automation and capacity build-out across US, Singapore, and China.Bestzyme advanced international expansion while increasing investment in AI-enabled protein engineering to speed industrial enzyme R&D.Reported results were weighed by GenScript’s equity-method exposure to Legend, including a large non-cash impairment, despite continued commercial traction for CARVYKTI.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDLbm5fnh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01548","BK1576","HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","HK0000306685.HKD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101454303","title":"Genscript Bio Plans Fifth Amended Memorandum and Articles to Comply with Updated HKEX Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=1101454303","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101454303?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:41","pubTimestamp":1775810499,"startTime":"0","endTime":"0","summary":"Genscript Bio announced on 10 April 2026 that its board intends to replace the current fourth amended and restated memorandum and articles of association with a fifth version, consolidating a series...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626119884","title":"GenScript seeks shareholder approval for bylaw updates on hybrid meetings, e-voting, treasury shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626119884","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626119884?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:32","pubTimestamp":1775809952,"startTime":"0","endTime":"0","summary":"GenScript Biotech flagged proposed amendments to its memorandum and articles of association to align governance with recent Hong Kong listing rule changes.Changes target hybrid general meetings, electronic voting, treasury shares, plus the uncertificated securities market regime.Board plans to adopt a fifth amended and restated memorandum and articles to replace existing documents in full.Amendments require shareholder approval via special resolution at upcoming annual general meeting.Revisions take effect upon shareholder passage at the AGM.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL7R6z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK1583","HK0000320223.HKD","01548","HK0000306685.HKD","BK1576","HK0000320264.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626184685","title":"GenScript partners with Mimulus to scale DNA-based data storage by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2626184685","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626184685?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:06","pubTimestamp":1775736418,"startTime":"0","endTime":"0","summary":"GenScript entered a multi-year strategic collaboration with Mimulus to industrialize DNA-based data storage for AI-era archival workloads.Partnership targets breakthrough cost efficiencies by 2030 through scaled molecular storage infrastructure.GenScript will industrialize high-throughput DNA synthesis, aiming to increase parallel output from 8 million oligonucleotides per chip to billions.Collaboration combines GenScript synthesis and sequencing-related capabilities with Mimulus Molecular Archive Technology to move DNA storage from lab development to commercial-scale deployment.Program includes Mimulus Glacier Data Storage Card, positioned as an off-grid archival alternative to magnetic tape and hard drives.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL5VRnpM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD","01548","HK0000320223.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122102811","title":"HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122102811","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122102811?lang=en_us&edition=fundamental","pubTime":"2026-04-09 09:49","pubTimestamp":1775699344,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks rallied in Hong Kong. $Joinn(06127)$ rose 7%; $Asymchem(06821)$ and $Pharmaron(03759)$ rose 4%; $WuXi AppTec(02359)$, $Genscript Biotech(01548)$, and $Tigermed(03347)$ rose 3%; $WuXi Biologics(02269)$ rose 2%.   ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"856cdb69403d887dc4a082d3a2a26688","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269","06127","03759","02359","03347","01548","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173846630","title":"Genscript Bio Adds 1.53 Million New Shares in March 2026, Issued Capital Reaches 2.19 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1173846630","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173846630?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:44","pubTimestamp":1775119465,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation filed its monthly return for the period ended 31 March 2026, detailing modest equity movements driven by employee incentive programmes. Authorised Share Capital   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575853","title":"Jefferies Adjusts Yeahka's Price Target to HK$15.50 From HK$23, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575853","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624575853?lang=en_us&edition=fundamental","pubTime":"2026-04-02 15:00","pubTimestamp":1775113208,"startTime":"0","endTime":"0","summary":"Genscript Biotech (HKG:1548) has an average rating of buy and mean price target of HK$19.07, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","HK0000306685.HKD","HK0000320264.USD","01548","HK0000306701.USD","BK1576","BK1141","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108591007","title":"GENSCRIPT BIO (01548) 2025 Annual Report Review: Synergistic Growth Across Three Core Businesses Highlights Systemic Competitive Advantages and Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1108591007","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108591007?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:15","pubTimestamp":1773825309,"startTime":"0","endTime":"0","summary":"On March 15, GENSCRIPT BIO (01548) released its full-year financial results for 2025. The past year showcased a clear and robust growth trajectory for the company. As a rapidly expanding enterprise...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","HK0000320223.HKD","HK0000320264.USD","BK1141","BK1576","BK1583","HK0000306701.USD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113306341","title":"Daiwa Cuts Target Price for GENSCRIPT BIO (01548) to HK$21, Reiterates \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1113306341","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113306341?lang=en_us&edition=fundamental","pubTime":"2026-03-18 14:28","pubTimestamp":1773815299,"startTime":"0","endTime":"0","summary":"Daiwa released a research report indicating that GENSCRIPT BIO (01548) delivered results in line with expectations last year. Sales increased by 61% year-on-year to $960 million, matching the firm's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000320264.USD","BK1576","01548","HK0000306685.HKD","BK1141","HK0000306701.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genscript.com","stockEarnings":[{"period":"1week","weight":0.0742},{"period":"1month","weight":0.1842},{"period":"3month","weight":-0.0234},{"period":"6month","weight":-0.1252},{"period":"1year","weight":0.3231},{"period":"ytd","weight":0.1079}],"compareEarnings":[{"period":"1week","weight":0.0103},{"period":"1month","weight":0.0052},{"period":"3month","weight":-0.0255},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.2227},{"period":"ytd","weight":0.0207}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.000341},{"month":2,"riseRate":0.545455,"avgChangeRate":0.075475},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.060575},{"month":4,"riseRate":0.545455,"avgChangeRate":0.058215},{"month":5,"riseRate":0.5,"avgChangeRate":0.068155},{"month":6,"riseRate":0.6,"avgChangeRate":0.044564},{"month":7,"riseRate":0.6,"avgChangeRate":0.075818},{"month":8,"riseRate":0.4,"avgChangeRate":0.101263},{"month":9,"riseRate":0.4,"avgChangeRate":-0.071937},{"month":10,"riseRate":0.6,"avgChangeRate":0.095918},{"month":11,"riseRate":0.6,"avgChangeRate":0.045101},{"month":12,"riseRate":0.3,"avgChangeRate":0.042047}],"exchange":"SEHK","name":"GENSCRIPT BIO","nameEN":"GENSCRIPT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GENSCRIPT BIO,01548,GENSCRIPT BIO股票,GENSCRIPT BIO股票老虎,GENSCRIPT BIO股票老虎国际,GENSCRIPT BIO行情,GENSCRIPT BIO股票行情,GENSCRIPT BIO股价,GENSCRIPT BIO股市,GENSCRIPT BIO股票价格,GENSCRIPT BIO股票交易,GENSCRIPT BIO股票购买,GENSCRIPT BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}